Kcs Wealth Advisory Bristol Myers Squibb CO Transaction History

Kcs Wealth Advisory

$224 Million
Q3 2023

A detailed history of Kcs Wealth Advisory transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kcs Wealth Advisory holds 24,038 shares of BMY stock, worth $1.3 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

24,038

Previous 26,497 9.28%

Holding current value

$1.3 Million

Previous $1.69 Million 17.65%

% of portfolio

0.62%

Previous 0.62%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $142,351 - $159,171	-2,459 Reduced 9.28%	24,038 $1.4 Million
Q2 2023 Jul 17, 2023	BUY	$63.71 - $70.74 $82,568 - $91,679	1,296 Added 5.14%	26,497 $1.69 Million
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $52,042 - $59,027	792 Added 3.24%	25,201 $1.75 Million
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $13,901 - $16,461	203 Added 0.84%	24,409 $1.76 Million
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $133 - $78,684	-1,024 Reduced 4.06%	24,206 $1.72 Million
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $47,929 - $52,786	660 Added 2.69%	25,230 $1.94 Million
Q1 2022 Apr 13, 2022	BUY	$61.48 - $73.72 $117,857 - $141,321	1,917 Added 8.46%	24,570 $1.79 Million
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $72,722 - $84,777	1,356 Added 6.37%	22,653 $1.41 Million
Q3 2021 Oct 20, 2021	BUY	$59.17 - $69.31 $111,239 - $130,302	1,880 Added 9.68%	21,297 $1.26 Million
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $149,141 - $162,414	2,409 Added 14.16%	19,417 $1.3 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $144,967 - $163,045	2,443 Added 16.77%	17,008 $1.07 Million
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $90,305 - $102,332	1,564 Added 12.03%	14,565 $903,000
Q3 2020 Oct 27, 2020	BUY	$57.43 - $63.64 $27,394 - $30,356	477 Added 3.81%	13,001 $784,000
Q2 2020 Jul 16, 2020	BUY	$54.82 - $64.09 $72,472 - $84,726	1,322 Added 11.8%	12,524 $736,000
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $105,142 - $152,796	2,266 Added 25.36%	11,202 $624,000
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $439,740 - $573,601	8,936 New	8,936 $574,000

Others Institutions Holding BMY

# of Institutions

2,404

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcs Wealth Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Kcs Wealth Advisory with notifications on news.

Account

Kcs Wealth Advisory Bristol Myers Squibb CO Transaction History